SLC5A2: Sodium/glucose cotransporter 2
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Electrogenic Na(+)-coupled sugar symporter that actively transports D-glucose at the plasma membrane, with a Na(+) to sugar coupling ratio of 1:1.
- Drugs that act on it: 14
- With a US drug page: 5
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Bexagliflozin | Approved | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Dapagliflozin | Approved | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Empagliflozin | Approved | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Ertugliflozin | Approved | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Sotagliflozin | Approved | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Canagliflozin anhydrous | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | Boxed warning |
| Henagliflozin | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Ipragliflozin | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Ipragliflozin l-proline | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Licogliflozin | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Remogliflozin etabonate | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Sergliflozin etabonate | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| Tofogliflozin anhydrous | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
| YM-543 free acid | — | Sodium/glucose cotransporter 2 inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Renal glycosuria
- 0.74
- Heart failure
- 0.63
- Disorder of carbohydrate metabolism
- 0.57
- Carbohydrate metabolism disease
- 0.52
- Glycosuria
- 0.46
- Hypertensive disorder
- 0.43
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- SLC5A2
Drugs and mechanisms are from ChEMBL CHEMBL3884 (CC BY-SA 3.0). Gene name, function (UniProt P31639, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets